Brief: Gensight Biologics Says Co Renegotiates Financial Obligations; Advancing On Discussions With Potential Partners On Strategic Opportunities
June 20 (Reuters) - Gensight Biologics SA SIGHT.PA :
* GENSIGHT BIOLOGICS RENEGOTIATES FINANCIAL OBLIGATIONS AND
PROVIDES OPERATIONAL UPDATES
* GENSIGHT : IS ADVANCING ON DISCUSSIONS WITH POTENTIAL
PARTNERS
ON STRATEGIC OPPORTUNITIES, INCLUDING A POSSIBLE MERGER,
ACQUISITION OR LICENSING DEAL,
Source text for Eikon: ID:nBw5W78wca
Further company coverage: SIGHT.PA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Gensight Biologics SA
See all newsHealth Rounds: Blindness treatment based on Nobel-winning research shows promise
France's GenSight Biologics H1 net loss widens on higher R&D expenses
Brief: GenSight Biologics H1 Net Income EUR -10.3 Million
France's GenSight Biologics 2025 net loss narrows on reduced R&D spending
Brief: GenSight Biologics FY EPS EUR -0.08